Toggle light / dark theme

If you’re wondering just how advanced artificial intelligence (AI) systems are getting, then know this: the US military is testing an experimental AI network tasked with identifying likely future events worthy of closer attention, and days before they occur.

The series of tests are called the Global Information Dominance Experiments (GIDE), and they combine data from a huge variety of sources, including satellite imagery, intelligence reports, sensors in the field, radar, and more.

Cloud computing also plays an important part in this setup, making sure that vast chunks of data collected from all over the world can be processed efficiently, and then accessed by whichever military officials and agencies need them.

Circa 2020


On 8 May 2020, the Institute of Agrifood Research and Technology (IRTA) reported the case of the first cat infected with SARS-CoV-2 in Spain. It was a 4-year-old cat called Negrito, who lived with a family affected by COVID-19, with one case of death.

Coinciding with these facts, the animal presented severe respiratory difficulties and was taken to a veterinary hospital in Badalona (Barcelona), where it was diagnosed with hypertrophic cardiomyopathy. Due to a terminal condition the hospital decided to do a humanitarian euthanasia.

The necropsy, performed at the High Biosafety Level Laboratories of the Animal Health Research Center (CReSA) at IRTA, confirmed that Negrito suffered from feline hypertrophic cardiomyopathy and had no other lesions or symptoms compatible with a coronavirus infection.

At the University of Chicago, scientists have developed an absolutely innovative, promising treatment for COVID-19 in the form of nanoparticles with the ability to trap SARS-CoV-2 viruses inside the body and use the body’s own immune system to kill them.

The “nanotraps” lure the virus by imitating the target cells infected by the virus. When the virus gets trapped by the nanotraps, it is then sequestered from other cells and targeted for destruction by the immune system.

Theoretically, these nanotraps could be used on different variants of the virus, resulting in a promising new way to suppress the virus in the future. The therapy is still in the early stages of testing, but the researchers believe that it could be administered through a nasal spray as a treatment for COVID-19.